---
figid: PMC9144399__pharmaceuticals-15-00523-g008
pmcid: PMC9144399
image_filename: pharmaceuticals-15-00523-g008.jpg
figure_link: /pmc/articles/PMC9144399/figure/pharmaceuticals-15-00523-f008/
number: Figure 8
figure_title: ''
caption: HMN-214 inhibits critical NB regulatory genes. Gene expression analysis of
  PLK1 pathway and cell cycle regulatory genes in response to HMN-214 in SH-SY5Y cells.
  (A) PLK1, (B) WEE1, (C) CDK1, (D) CDK2, (E) MYC, (F) CCNB1 (Cyclin-B1), (G) CHEK1
  (CHK1), (H) CHEK2 (CHK2), and (I) MDM2. * p < 0.05, ** p < 0.01, *** p < 0.001,
  **** p < 0.0001.
article_title: Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression
  and Inhibits Neuroblastoma Growth.
citation: Rameswari Chilamakuri, et al. Pharmaceuticals (Basel). 2022 May;15(5):523.
year: '2022'

doi: 10.3390/ph15050523
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- pediatric cancer
- neuroblastoma
- HMN-214
- cell cycle
- PLK1

---
